论文信息 - Phase II efficacy and safety study of nintedanib versus sunitinib in previously untreated renal cell carcinoma (RCC) patients. - 字舞流文

Phase II efficacy and safety study of nintedanib versus sunitinib in previously untreated renal cell carcinoma (RCC) patients.

R. Kaiser | I. Bondarenko | T. Eisen | Y. Shparyk | M. Studeny | N. MacLeod | Robert R Jones | G. Temple | A. Loembé | H. Finnigan | Robert Jones | Nicholas James MacLeod